Return to search results
Tafluprost
Tafluprost Ophthalmic (brand name Zioptan) is a prescription eye drop medication containing the active ingredient tafluprost, a prostaglandin analog. It works by increasing fluid drainage from the eye to lower intraocular pressure, commonly used to treat glaucoma or ocular hypertension. Apply one drop to the affected eye(s) once daily. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tafluprost Ophthalmic (brand name Zioptan) is a prescription eye drop medication containing the active ingredient tafluprost, a prostaglandin analog. It works by increasing fluid drainage from the eye to lower intraocular pressure, commonly used to treat glaucoma or ocular hypertension. Apply one drop to the affected eye(s) once daily. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tafluprost",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tafluprost — ANDA 202514 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202514"
}
]
|
| identifier | ANDA202514 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"health-care",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tafluprost |
